NCT03375983 2024-02-20Plasmodium Immunotherapy for Advanced CancersCAS Lamvac Biotech Co., Ltd.Phase 1/2 Recruiting20 enrolled
NCT02561234 2021-11-05A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid TumorsAeglea BiotherapeuticsPhase 1/2 Completed98 enrolled